← back to search

Wei Wang

China Pharmaceutical University · CN
Area of research
Molecular Biology · Biomedical Engineering
Research interest
Research interests include RNA Interference and Gene Delivery, Nanoplatforms for cancer theranostics, Pharmacological Effects of Natural Compounds, and Nanoparticle-Based Drug Delivery.
h-index
59
citations
11,757
works
421
NIH funding
primary concept
email

Recent publications

Efficacy and safety of Qishen granule for treating heart failure with preserved ejection fraction: a study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
BMC Complementary Medicine and Therapies 2025cited by 0position: lastdoi
Intelligent bacteria‐targeting ZIF‐8 composite for fluorescence imaging‐guided photodynamic therapy of drug‐resistant superbug infections and burn wound healing
Exploration 2024cited by 89position: middledoi
Drug Interactions between Traditional Chinese Medicines and Cardiovascular Drugs
European Journal of Drug Metabolism and Pharmacokinetics 2024cited by 4position: middledoi
pH-mediated potentiation of gallium nitrate against Pseudomonas aeruginosa
Frontiers in Microbiology 2024cited by 1position: middledoi
APN Expression in Serum and Corpus Luteum: Regulation of Luteal Steroidogenesis Is Possibly Dependent on the AdipoR2/AMPK Pathway in Goats
Cells 2023cited by 5position: middledoi
Voriconazole therapeutic drug monitoring and hepatotoxicity in critically ill patients: A nationwide multi-centre retrospective study
International Journal of Antimicrobial Agents 2022cited by 36position: middledoi
Nanoparticle-Mediated Targeted Drug Delivery to Remodel Tumor Microenvironment for Cancer Therapy
International Journal of Nanomedicine 2021cited by 90position: middledoi
The montreal cognitive assessment and mini-mental state examination visuoexecutive subtests in acute ischemic stroke patients and their correlations with demographic and clinical factors
Acta Neurologica Belgica 2020cited by 1position: firstdoi
Design and synthesis of the novel oleanolic acid-cinnamic acid ester derivatives and glycyrrhetinic acid-cinnamic acid ester derivatives with cytotoxic properties
Bioorganic Chemistry 2019cited by 78position: middledoi
Fatty-acid receptor CD36 functions as a hydrogen sulfide-targeted receptor with its Cys333-Cys272 disulfide bond serving as a specific molecular switch to accelerate gastric cancer metastasis
EBioMedicine 2019cited by 49position: middledoi
Prognostic Significance of PSMD1 Expression in Patients with Gastric Cancer
Journal of Cancer 2019cited by 24position: middledoi
On-Demand Versatile Prodrug Nanomicelle for Tumor-Specific Bioimaging and Photothermal-Chemo Synergistic Cancer Therapy
ACS Applied Materials & Interfaces 2018cited by 50position: lastdoi
Activation of ERK and Mutual Regulation of Stat3 and SP1 Contribute to Inhibition of PDK1 Expression by Atractylenolide-1 in Human Lung Cancer Cells
Cellular Physiology and Biochemistry 2017cited by 27position: middledoi
Differential effects of sulforaphane in regulation of angiogenesis in a co-culture model of endothelial cells and pericytes
Oncology Reports 2017cited by 13position: middledoi
Signaling pathways of docosahexenoic acid-induced apoptosis of prostate cancer cells
Zhonghua shiyan waike zazhi 2017cited by 0position: middledoi
Promoting apoptosis effect of polyunsaturated fatty acids in prostate adenocarcinoma cells
Zhonghua shiyan waike zazhi 2016cited by 0position: middledoi
Extraction optimization, characterization and antioxidant activity in vitro of polysaccharides from mulberry (Morus alba L.) leaves
Carbohydrate Polymers 2015cited by 214position: middledoi
Sulforaphane Protects the Liver against CdSe Quantum Dot-Induced Cytotoxicity
PLoS ONE 2015cited by 33position: firstdoi
Extraction, preliminary characterization and antioxidant activity of Se-enriched Maitake polysaccharide
Carbohydrate Polymers 2013cited by 86position: middledoi
A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy
Biomaterials 2012cited by 126position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yongping Bao · University of East Anglia2 papers (2015–2017)Xiaopeng Jia · Hebei Medical University2 papers (2016–2017)Xiuli Wang · Hebei Medical University2 papers (2016–2017)Zhe Wang · Tufts University1 papers (2019–2019)Yang Li · Beijing University of Chinese Medicine1 papers (2019–2019)Jingjing Wang · Hefei University of Technology1 papers (2022–2022)Rui Wang · KU Leuven1 papers (2019–2019)Jun Zhang · First Affiliated Hospital of Hunan University of Traditional Chinese Medicine1 papers (2022–2022)Lei Wang · Dongguan People’s Hospital1 papers (2025–2025)Jie Zhang · Fudan University1 papers (2024–2024)Yu Wang · University of Jinan1 papers (2012–2012)Hao Liu · Zhejiang Chinese Medical University1 papers (2019–2019)Miao Liyan · Jiangsu University1 papers (2022–2022)Sihan Li · Fudan University1 papers (2022–2022)Yiqing Fan · Shandong University1 papers (2019–2019)Xiaohui Wang · Henan Academy of Sciences1 papers (2019–2019)Jiaojiao Chen · Wenzhou Medical University1 papers (2022–2022)Zhibo Li · Guangzhou University of Chinese Medicine1 papers (2025–2025)Haolin Li · Nanjing Agricultural University1 papers (2023–2023)Yanan Sun · Qingdao University of Science and Technology1 papers (2016–2016)